Sun Pharmaceutical Industries

Press release regarding intimation of DCGI approval to manufacture and market generic semaglutide injection in India for chronic weight management

23 Jan, 2026 | 08:21am • Source: BSE

Response to Rumour verification letter from BSE

19 Jan, 2026 | 12:46pm • Source: BSE

The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on January 19, 2026, with reference to news appeared in https://www.news18.com/ dated January 19, 2026...

19 Jan, 2026 | 10:55am • Source: BSE

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India

14 Jan, 2026 | 02:41pm • Source: BSE

Intimation regarding Certificate of Compliance

09 Jan, 2026 | 07:46pm • Source: BSE

Closure of Trading Window

29 Dec, 2025 | 04:37pm • Source: BSE

SPIL Investor Presentation -Dec 2025

26 Dec, 2025 | 02:51pm • Source: BSE

Newspaper Advertisement

23 Dec, 2025 | 01:10pm • Source: BSE

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 US FDA determines Baska facility inspection classification as OAI

18 Dec, 2025 | 10:02am • Source: NSE

US FDA determines Baska facility inspection classification as OAI

18 Dec, 2025 | 08:25am • Source: BSE

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated December 01, 2025, titled "Sun Pharma introduces its global innovative drug, Ilumya®...

01 Dec, 2025 | 10:04am • Source: NSE

Sun Pharma introduces Ilumya in India for the treatment of moderate-to-severe Plaque Psoriasis.

01 Dec, 2025 | 09:11am • Source: BSE

Press Release

26 Nov, 2025 | 10:29am • Source: BSE

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 26, 2025

26 Nov, 2025 | 09:39am • Source: NSE

AstraZeneca Pharma India and Sun Pharma partner to help patients living with Hyperaklaemia in India

17 Nov, 2025 | 04:05pm • Source: BSE

Press Releases

12 Nov, 2025 | 04:04pm • Source: BSE

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 12, 2025, titled "Philogen provides update on Fibromun clinical study developments

12 Nov, 2025 | 09:28am • Source: NSE

Press Release

12 Nov, 2025 | 08:58am • Source: BSE

Q2 FY26 Earnings Call Transcript

11 Nov, 2025 | 04:00pm • Source: BSE

Intimation of Schedule of Analyst/Institutional Investor Meeting

10 Nov, 2025 | 05:04pm • Source: BSE